• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Zoetis Stock Has More Room to Run

ZTS is in a longer-term uptrend that should continue when the weakness in the broader market subsides.
By BRUCE KAMICH
Dec 20, 2021 | 10:33 AM EST
Stocks quotes in this article: ZTS

Shares of global animal health company Zoetis (ZTS) have been climbing higher and higher the past year. When we last reviewed the charts of ZTS way back on Jan. 21 we wrote that, "It looks like ZTS can move higher in 2021 as our weekly chart and the Point and Figure chart suggest. The question is when. I would anticipate some further sideways price action before renewed strength. Buyers need to be patient."

Let's check in on the charts again.

In the updated daily bar chart of ZTS, below, we can see that buyers indeed had to be patient until early April when the uptrend resumed. Prices reached our Point and Figure target of $194 in early July and have continued higher after a correction in September. ZTS is trading above the rising 50-day moving average line and the rising 200-day average line.
 
The On-Balance-Volume (OBV) line has been steady since July but may have started a new leg higher in December. The Moving Average Convergence Divergence (MACD) oscillator is in a bullish alignment above the zero line.
 
 
In the weekly Japanese candlestick chart of ZTS, below, we see a bullish picture. Prices have maintained a longer-term uptrend the past three years. The slope of the 40-week moving average line is positive.
 
The weekly OBV line is bullish. The MACD oscillator is also bullish.
 
 
In this daily Point and Figure chart of ZTS, below, we can see that the software is projecting a potential upside price target in the $325 area.
 
 
Bottom-line strategy: ZTS is in a longer-term uptrend that should continue when the weakness in the broader market averages abates. Traders could go long ZTS on available weakness risking to $222. The $325 area is our Point and Figure price target.
 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Healthcare | Pharmaceuticals | Consumer Discretionary

More from Stocks

LyondellBasell Could Hold Temporarily Before Renewed Declines

Bruce Kamich
Jun 27, 2022 2:22 PM EDT

Let's take a look.

Kass: Why Markets Could Make a Yankees-Like Comeback

Doug Kass
Jun 27, 2022 2:00 PM EDT

I remain uncharacteristically bullish. Here's why.

If You Buy Now in This Bear-Bull Battle, You May Be Paying Later

Bob Lang
Jun 27, 2022 1:00 PM EDT

You really want to snag a bargain -- and bank a win -- right now. Here's a better strategy.

Should You Buy Micron Technology Ahead of Earnings?

Bruce Kamich
Jun 27, 2022 12:20 PM EDT

The chipmaker reports its latest quarterly results this week.

Do Not Leave Texas Roadhouse on the Grill Too Long

Bruce Kamich
Jun 27, 2022 11:40 AM EDT

Here's how traders can smartly play the restaurant chain

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:04 AM EDT PAUL PRICE

    Two Good Signs -- Especially for Small-Cap Investors

  • 12:10 AM EDT PAUL PRICE

    More Insider Buying in American Woodmark (AMWD)

    American Woodmark , which I've discussed here fr...
  • 08:55 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The 10 personality traits of successful traders an...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login